Navigation Links
S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
Date:2/28/2011

SINGAPORE, Feb. 28, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced that its novel dual mTOR/PI3 Kinase inhibitor SB2343 demonstrated excellent pharmacokinetic/pharmacodynamic (PK/PD) properties leading to significant anti-tumor efficacy in rapamycin-sensitive and resistant xenograft models. In vivo and in vitro data on SB2343 were presented at American Association of Cancer Research (AACR) Special Conference on Targeting PI3K/mTOR Signaling in Cancer held in San Francisco.

SB2343 is a uniquely selective and orally active mTOR/PI3 Kinase inhibitor that targets the PI3K signalling pathway with high and equivalent potency against both mTOR and PI3K enzymes.  The combined modulation of these two kinases with SB2343 provides an attractive and powerful therapeutic approach for the treatment of patients with a wide range of cancers alone or in combination.

"The pre-clinical data for our mTOR/PI3K inhibitor SB2343 strongly demonstrate its unique treatment potential in a broad range of cancers that are dependent on elevated PI3K signalling," said Jan-Anders Karlsson, CEO of S*BIO. "The advancement of our diversified pipeline shows our continued commitment to develop high quality products in the oncology area."

Abstracts:Poster Session A (Friday, February 25th)SB2343, a novel tetra-substituted purine, inhibits mTOR and PI3K equipotently, has favorable pharmacokinetic and pharmacodynamic properties and is orally efficacious in various cancer models

SB2343 is a potent dual mTOR/PI3K inhibitor with excellent pharmaceutical and pharmacodynamic properties, tolerability and anti-tumor efficacy.  SB2343 has therapeutic potential for the treatment of a broad range of Rapamycin-sensitive, but also – resistant cancers. Efficacious doses of SB2343 were selected after pharmacokinetic and biomarker analysis of PC3 tumor-bearing mice, treated with single oral doses.  Anti-tumor efficacy of SB2343 was evaluated in
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reportlinker Adds Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
2. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
3. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
4. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
5. Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
6. Novel Night Time Healing is Key to Shoulder Pain Relief From ROTATORELIEVER
7. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
8. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
9. Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence
10. IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs
11. Omeros Licenses Novel Antifibrinolytic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of 18,200,000 shares of its common stock in an ... of $11.00 per share, before underwriting discounts. J.P. Morgan, ... as joint book-running managers for the offering. Piper ... for the offering. Avanir has granted the underwriters a ...
(Date:9/23/2014)... 2014  Echo Therapeutics, Inc. (NASDAQ: ... that, as it believes that its current liquidity ... 30, 2014, it has suspended its product development, ... conserve its liquidity and capital resources. ... Echo,s current financial position, funding alternatives, and projected ...
(Date:9/23/2014)... Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe ... Italy , UK, Spain ) Summary GBI ... Europe ( Germany , France , ... analysis of the transcatheter heart valves market in Europe . ... period and key company share data by revenue in 2013 for the following ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3Echo Therapeutics Suspends Operations To Conserve Liquidity 2Echo Therapeutics Suspends Operations To Conserve Liquidity 3Echo Therapeutics Suspends Operations To Conserve Liquidity 4Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2
... LAUSANNE, Switzerland, October 15 ... integrated molecular and,immunodiagnostics based on its proprietary micro-technology platform, ... financing round. The,Company raised EUR 10 million ( USD ... , The deal was led ...
... Ganey Associates, Inc. today announced a broad partnership with ... help measure and improve satisfaction and engagement among patients, ... on October 1, 2009. , HMA owns and operates ... licensed beds, in non-urban communities located throughout the United ...
Cached Medicine Technology:Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3Press Ganey Partners With Health Management Associates 2
(Date:9/23/2014)... 24, 2014 Getting braces is ... list — teenager nor adult — but Fredericksburg ... process a little less painful. Make an appointment ... Dentistry to receive a free Invisalign consultation, and ... Invisalign is a new teeth-straightening system that works ...
(Date:9/23/2014)... TX (PRWEB) September 24, 2014 ... can help., For roughly half of women, menopause ... on symptoms more commonly associated with major depressive ... anxiety, irritability, sleep disturbances, memory loss, and fatigue. ... their potential side effects and high cost make ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Today, ... announced today the publication of a new eBook, ... help employers and health insurance professionals perform a ... According to Zane Benefits, over the next three ... cancel group health insurance coverage in favor of ...
(Date:9/23/2014)... NV (PRWEB) September 23, 2014 ... that is helping online marketers easily build simple, attractive, ... maximize their profit generation has caught the attention of ... of the most difficult aspects of making money online ... advertising and attracting traffic, and the profits that are ...
(Date:9/23/2014)... 2014 Mirena IUD lawsuits ( http://www.themirenalawsuitcenter.com/ ... migration of the birth control device continue to mount ... According to court documents dated September 18th, an Iowa ... the IUD outside of the uterus caused the device ... is now pending in the U.S. District Court, Northern ...
Breaking Medicine News(10 mins):Health News:Fredericksburg & Montclair Family Dentistry: Now Offering Invisalign Consultation Treatment Discount 2Health News:Pristiq Discounts Now Available from MedicationDiscountCard.com To Help Ease Menopause Symptoms 2Health News:Zane Benefits Announces New Worksheets on Employer-Funded Individual Health Insurance 2Health News:ClickFunnels: Review Examines Russell Brunson’s Latest Sales Funnel Building Software 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4
... Act on Capitol Hill, WASHINGTON, April 24 ... and questions for the patient, their families and,caregivers. ... cancer care by affording the patient the opportunity ... thought the cancer diagnosis, treatment,and follow up care., ...
... Boxer and Feinstein to quickly pass,companion bill and send ... AARP thanked,the supporters and cosponsors of the Protecting the ... the U.S. House of Representatives. The bill,prevents massive increases ... proposed by the administration., "Today,s vote is a ...
... concern,over health care costs and economic issues, American ... retirement decreased over the past year,by a rate ... Confidence Survey(R),(RCS), according to just-released survey results., , ... to:, http://www.prnewswire.com/mnr/ebri/32335/ , The percentage of workers ...
... April 23 Aflac,Incorporated today reported its first ... Total revenues were $4.3 billion during the ... the first quarter of 2007. Net earnings were,$474 ... $416 million, or,$.84 per share, a year ago. ...
... April 23 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ... and hospitals throughout the United States,today announced that it ... at 4:30 p.m. (EDT) with management to review the ... Web Cast, A live and archived webcast will ...
... Quickly Pass Companion,Bill and Send Measure to President, ... of the Protecting the Medicaid Safety Net Act of,2008, ... The bill,prevents massive increases in costs for people in ... "Today,s vote is a victory for all Illinoisans who ...
Cached Medicine News:Health News:Support for Patient Navigation Services to Help Cancer Patients 2Health News:AARP Thanks California's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Video: 18th Annual Retirement Confidence Survey(R): Health Care, Economy Major Concerns in Workers' Record Drop in Retirement Confidence 2Health News:Video: 18th Annual Retirement Confidence Survey(R): Health Care, Economy Major Concerns in Workers' Record Drop in Retirement Confidence 3Health News:Video: 18th Annual Retirement Confidence Survey(R): Health Care, Economy Major Concerns in Workers' Record Drop in Retirement Confidence 4Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 2Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 3Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 4Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 5Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 6Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 7Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 8Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 9Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 10Health News:NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results 2Health News:AARP Commends Illinois U.S. Reps for Voting to Protect People in Medicaid 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: